Get Live Data

George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here. 

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Novartis Adr Re Share Price

Pin to quick picksNovartis Adr Re Share Price (0K9E)

Novartis Adr Re Information

Share Price Information for Novartis Adr Re (0K9E)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.85311
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 96.85311
0K9E Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Novartis Ag Novartis Adr Representing 1 Ord Shs

Novartis Ag Novartis Adr Representing 1 Ord Shs is listed on the London Stock Exchange trading with ticker code 0K9E.L. It has a market capitalisation of $197.62b, with approximately 2.04b shares in issue. Over the last year, Novartis Adr Re share price has been traded in a range of 14.9405, hitting a high of 107.64855, and a low of 92.7085.

Intraday Novartis Adr Re Share Chart

Novartis Adr Re Share Price
Price 96.85311
Bid 0.00
Ask 0.00
Change 0.00 (0.00%)
Volume 5
Open 0.00
High 0.00
Low 0.00
Prev. Close 96.85311

3 Month Novartis Adr Re Share Graph

Currency USD
Issue Country CH
Shares in Issue 2.04b
Market Capitalisation $197.62b
Market Size 0
52 Week High 107.64855
52 Week High Date 12-Jan-2024
52 Week Low 92.7085
52 Week Low Date 22-Apr-2024
# Trades 7
Vol. Sold 0
Sold Value $N/A
Vol. Bought 0
Bought Value $N/A
PE Ratio 13.54589
Earnings 7.15
Dividend 3.498699
Yield 3.612%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Novartis Adr Re (0K9E)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
26-Apr-2420:04:2697.740420Unknown*0.000.001,955O Ordinary
Delayed publication
Historical
Was reported as OTC
26-Apr-2419:30:5697.742Unknown*0.000.00195.48O Ordinary
Delayed publication
Historical
29-Apr-2401:00:0897.605Unknown*0.000.00488.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2419:33:1497.682300Unknown*0.000.0029.30kO Ordinary
Delayed publication
Historical
Was reported as OTC
26-Apr-2420:49:5197.61534Unknown*0.000.003,319O Ordinary
Delayed publication
Historical
Was reported as OTC
26-Apr-2420:59:2397.49218Unknown*0.000.001,755O Ordinary
Delayed publication
Historical
Was reported as OTC
26-Apr-2419:33:1597.682190Unknown*0.000.0018.56kO Ordinary
Delayed publication
Historical
Was reported as OTC
View more Novartis Adr Re trades

Directors Deals for Novartis Adr Re (0K9E)

Announced Traded Action Notifier Price Currency Amount Holding
  • No Directors Deals found.
View more Novartis Adr Re directors deals
  • There are no chat posts for Novartis Adr Re
View more Novartis Adr Re share chat

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.